Zenlabs Ethica Intrinsic Value
Zenlabs Ethica (ZENLABS) median intrinsic value is ₹52.00 from 3 valuation models (range ₹13–₹65), vs current price ₹26.00 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Analyse ZENLABS promoter holding to track promoter, FII and institutional holdings.
ZENLABS Valuation Methods Summary — DCF, Graham Number & P/E
Zenlabs Ethica intrinsic value across 3 models vs current price ₹26.00 — upside/downside and value range per method. Read ZENLABS dividend payout details for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹12.86 | ₹11.57 - ₹14.15 | -50.5% | Book Value/Share: ₹12.86, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.00 | ₹46.80 - ₹57.20 | +100.0% | Revenue/Share: ₹71.43, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹65.00 | ₹52.00 - ₹78.00 | +150.0% | CF Growth: 15.0%, Discount: 15% |
ZENLABS Intrinsic Value vs Market Price — All Valuation Models
Zenlabs Ethica fair value range ₹13–₹65 vs current market price ₹26.00 across 3 valuation models. For current market price and key ratios, visit ZENLABS share price.
ZENLABS Intrinsic Value Analysis — Undervalued or Overvalued?
Zenlabs Ethica median intrinsic value ₹52.00, current price ₹26.00 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of ZENLABS?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Zenlabs Ethica (ZENLABS) is ₹52.00 (median value). With the current market price of ₹26.00, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹12.86 to ₹65.00, indicating ₹12.86 - ₹65.00.
Is ZENLABS undervalued or overvalued?
Based on our multi-method analysis, Zenlabs Ethica (ZENLABS) appears to be trading below calculated value by approximately 100.0%.
ZENLABS Financial Health — Key Ratios vs Industry Benchmarks
Zenlabs Ethica financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 17.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -33.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -2.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.35x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ZENLABS Cash Flow Quality — Operating & Free Cash Flow
Zenlabs Ethica operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-9 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-8 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |